Newborn blood spot screening for galactosemia, tyrosinemia type I, homocystinuria, sickle cell anemia, sickle cell/beta-thalassemia, sickle cell/hemoglobin C disease, and severe combined immunodeficiency

Simple item page
dc.contributor.authorWaye, Arianna
dc.contributor.authorEl Shayeb, Mohamed
dc.contributor.authorGuo, Bing
dc.contributor.authorChuck, Anderson
dc.contributor.authorAkpinar, Ilke
dc.contributor.authorChojecki, Dagmara
dc.contributor.authorYan, Charles
dc.contributor.authorCorabian, Paula
dc.date.accessioned2025-05-01T21:01:30Z
dc.date.available2025-05-01T21:01:30Z
dc.date.issued2016/03/23
dc.descriptionThis STE report examines the safety, screening accuracy, therapeutic efficacy/effectiveness, cost-effectiveness, budget impact, and health system readiness of newborn screening for seven conditions (galactosemia, tyrosinemia type I, homocystinuria, sickle cell anemia, sickle cell/beta-thalassemia, sickle cell/hemoglobin C disease, and severe combined immunodeficiency), contextualized to the Alberta setting.
dc.identifier.doihttps://doi.org/10.7939/R3Z02ZP8Q
dc.language.isoen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectBlood spot screening
dc.subjectNewborn screening
dc.titleNewborn blood spot screening for galactosemia, tyrosinemia type I, homocystinuria, sickle cell anemia, sickle cell/beta-thalassemia, sickle cell/hemoglobin C disease, and severe combined immunodeficiency
dc.typehttp://purl.org/coar/resource_type/c_93fc
ual.jupiterAccesshttp://terms.library.ualberta.ca/public

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
newborn_blood_spot_screening-20(1).pdf
Size:
5.08 MB
Format:
Adobe Portable Document Format
Download

Collections

Social, Technological and Economic (STE) Report (IHE)